Ön Beyin Gelişimsel Bozuklukları
Özet
Ön beyin gelişimsel bozuklukları, serebral korteksin gestasyonun erken dönemlerindeki karmaşık bölünme ve orta hat oluşum süreçlerinin aksamasından kaynaklanan holoprozensefali, korpus kallozum agenezisi ve septo-optik displazi gibi çeşitli nörolojik malformasyonları kapsar. Bu anomaliler genetik yatkınlıklar ve çevresel teratojenlerin etkisiyle ortaya çıkabilmekte, şiddetlerine göre epilepsi, zihinsel yetersizlik, motor gelişim geriliği ve endokrin sorunlar gibi geniş bir klinik tabloya yol açmaktadır. Tanı aşamasında fetal ultrason ve MRI görüntüleme yöntemleri kritik rol oynarken, yönetimi ise multidisipliner bir yaklaşımla semptomatik destek ve genetik danışmanlığı içermektedir.
Developmental disorders of the forebrain encompass neurological malformations such as holoprosencephaly, agenesis of the corpus callosum, and septo-optic dysplasia, which arise from disruptions in the complex cleavage and midline formation processes of the cerebral cortex during early gestation. These anomalies, driven by both genetic predispositions and environmental teratogens, present a wide clinical spectrum ranging from epilepsy and intellectual disability to motor developmental delays and endocrine dysfunction. While fetal ultrasound and MRI are critical for prenatal diagnosis, clinical management requires a multidisciplinary approach focusing on symptomatic support and genetic counseling.
Referanslar
Gleeson JG, Walsh CA. Neuronal migration disorders: from genetic diseases to developmental mechanisms. Trends Neurosci. 2000 Aug;23(8):352-9.
Volpe P, Campobasso G, De Robertis V, Rembouskos G. Disorders of prosencephalic development. Prenat Diagn. 2009 Apr;29(4):340-54.
Fernandes M, Hébert JM. The ups and downs of holoprosencephaly: dorsal versus ventral patterning forces. Clin Genet. 2008 May;73(5):413-23.
Plessis AJ, Johnston MV. Fetal Neurology. Arzimanoglou A, O’Hare A, Johnston MV, Ouvrier R, edt. Aicardi’s Diseases of the Nervous System in Childhood. 4th edn. London: Mac Keith Press; 2018. pp: 23.
Palmer EE, Mowat D. Agenesis of the corpus callosum: a clinical approach to diagnosis. Am J Med Genet C Semin Med Genet. 2014 Jun;166C(2):184-97.
Golden, J. A. Towards a greater understanding of the pathogenesis of holoprosencephaly. Brain Dev. 21, 513–521 (1999).
Bullen, P. J., Rankin, J. M. & Robson, S. C. Investigation of the epidemiology and prenatal diagnosis of holoprosencephaly in the North of England. Am. J. Obstet. Gynecol. 184, 1256–1262 (2001).
Forrester, M. B. & Merz, R. D. Epidemiology of holoprosencephaly in Hawaii, 1986-97. Paediatr. Perinat. Epidemiol. 14, 61–63 (2000).
Elliott H. Sherr, Jin S. Disorders of Forebrain Development. Swaiman KF, Ashwal S, Ferriero DM, Schor NF, Finkel RS, Gropman AL edt. Swaiman’s pediatric neurology. 6th edn. Edinburgh: Elsevier Saunders; 2018 pp. e459-475.
Posada, M. & Castillo, M. Middle interhemispheric variant of holoprosencephaly. Pediatr. Radiol. 40, 1843 (2010).
Hahn JS, et al. Septopreoptic holoprosencephaly: a mild subtype associated with midline craniofacial anomalies. AJNR Am J Neuroradiol 2010;31(9):1596–601.
Hahn, J. S. & Plawner, L. L. Evaluation and management of children with holoprosencephaly. Pediatr. Neurol. 31, 79–88 (2004).
Johnson, C. Y. & Rasmussen, S. A. Non-genetic risk factors for holoprosencephaly. Am. J. Med. Genet. Part C Semin. Med. Genet. 154, 73–85 (2010).
Siebert JR, et al. Syndromes. Holoprosencephaly An overview and atlas of cases. New York: Wiley-Liss; 1990.tle.
Roessler, E. & Muenke, M. The molecular genetics of holoprosencephaly. Am. J. Med. Genet. Part C Semin. Med. Genet. 154, 52–61 (2010).
Belloni E, et al. Identification of Sonic hedgehog as a candidate gene responsible for holoprosencephaly. Nat Genet 1996; 14(3):353–6.
Haas D, Muenke M. Abnormal sterol metabolism in holoprosencephaly. Am J Med Genet C Semin Med Genet. 2010;154C: 102-108.
Kelley RL, et al. Holoprosencephaly in RSH/Smith-Lemli-Opitz syndrome: does abnormal cholesterol metabolism affect the function of Sonic Hedgehog? Am J Med Genet 1996;66(4): 478–84.
Ming JE, Muenke M. Multiple hits during early embryonic development: digenic diseases and holoprosencephaly. Am J Hum Genet 2002;71(5):1017–32.
Olsen CL, Hughes JP, Youngblood LG, et al. Epidemiology of holoprosencephaly and phenotypic characteristics of affected children: New York State, 1984–1989. Am J Med Genet. 1997;73:217-226.
Croen LA, Shaw GM, Lammer EJ. Holoprosencephaly: epidemiologic and clinical characteristics of a California population. Am J Med Genet 1996;64(3):465–72.
Barr M Jr, Cohen MM Jr. Holoprosencephaly survival and per- formance. Am J Med Genet 1999;89(2):116–20.
Plawner LL, et al. Neuroanatomy of holoprosencephaly as predictor of function: beyond the face predicting the brain. Neurol- ogy 2002;59(7):1058–66.
Weiss, K., Kruszka, P. S., Levey, E. & Muenke, M. Holoprosencephaly from conception to adulthood. Am. J. Med. Genet. Part C Semin. Med. Genet. 178, 122–127 (2018).
Hayashi Y, Suzumori N, Sugiura T, et al. Prenatal findings of holoprosencephaly. Congenit Anom (Kyoto). 2015;55:161-163.
Verlinsky Y, Rechitsky S, Verlinsky O, et al. Preimplantation diagnosis for sonic hedgehog mutation causing familial holoprosencephaly. N Engl J Med. 2003;348:1449-1454.
Roach E, et al. Holoprosencephaly: birth data, benetic and demographic analyses of 30 families. Birth Defects Orig Artic Ser 1975;11(2):294–313.
Mercier S, et al. Genetic counseling and “molecular” prenatal diagnosis of holoprosencephaly (HPE). Am J Med Genet C Semin Med Genet 2010;154C(1):191–6.
Pineda-Alvarez DE, et al. Current recommendations for the molecular evaluation of newly diagnosed holoprosencephaly patients. Am J Med Genet C Semin Med Genet 2010;154C(1): 93–101.
Aboitiz F, Montiel J. One hundred million years of interhemispheric communication: the history of the corpus callosum. Braz J Med Biol Res. 2003 Apr;36(4):409-20.
Glass HC, et al. Agenesis of the corpus callosum in California 1983-2003: a population-based study. Am J Med Genet A 2008;146A(19):2495–500.
Sajan SA, et al. Both rare and de novo copy number variants are prevalent in agenesis of the corpus callosum but not in cerebellar hypoplasia or polymicrogyria. PLoS Genet 2013;9(10):e1003823.
Barkovich AJ. Analyzing the corpus callosum. AJNR Am J Neuroradiol 1996;17(9):1643–5.
Gazzaniga MS. Cerebral specialization and interhemispheric communication: does the corpus callosum enable the human condition? Brain 2000;123(Pt 7):1293–326.
Bloom JS, Hynd GW. The role of the corpus callosum in interhemispheric transfer of information: excitation or inhibition? Neuropsychol Rev 2005;15(2):59–71.
Wang LW, Huang CC, Yeh TF. Major brain lesions detected on sonographic screening of apparently normal term neonates. Neuroradiology 2004;46(5):368–73.
Durkin MS, et al. Advanced parental age and the risk of autism spectrum disorder. Am J Epidemiol 2008;168(11):1268–76.
Plasencia W, et al. Assessment of the corpus callosum at 20-24 weeks’ gestation by three-dimensional ultrasound examination. Ultrasound Obstet Gynecol 2007;30(2):169–72.
Ramelli G, et al. The prognosis of agenesis of the corpus callosum might mostly be favorable. Swiss Med Wkly 2006; 136(25–26):404–5.
Tang PH, et al. Agenesis of the corpus callosum: an MR imaging analysis of associated abnormalities in the fetus. AJNR Am J Neuroradiol 2009;30(2):257–63.
Moutard ML, et al. Agenesis of corpus callosum: prenatal diagnosis and prognosis. Childs Nerv Syst 2003;19(7–8):471–6.
Timor-Tritsch IE. As technology evolves, so should its application: shortcomings of the “18-week anatomy scan.”. J Ultrasound Med 2006;25(4):423–8.
Donahoo AL, Richards LJ. Understanding the mechanisms of callosal development through the use of transgenic mouse models. Semin Pediatr Neurol 2009;16(3):127–42.
Boland E, et al. Mapping of deletion and translocation breakpoints in 1q44 implicates the serine/threonine kinase AKT3 in postnatal microcephaly and agenesis of the corpus callosum. Am J Hum Genet 2007;81(2):292–303.
Bennett GL, Bromley B, Benacerraf BR. Agenesis of the corpus callosum: prenatal detection usually is not possible before 22 weeks of gestation. Radiology 1996;199(2):447–50.
Hetts SW, et al. Anomalies of the corpus callosum: an MR analysis of the phenotypic spectrum of associated malformations. AJR Am J Roentgenol 2006;187(5):1343–8.
Nakata Y, et al. Diffusion abnormalities and reduced volume of the ventral cingulum bundle in agenesis of the corpus callosum: a 3T imaging study. AJNR Am J Neuroradiol 2009;30(6): 1142–8.
Tovar-Moll F, et al. Structural and functional brain rewiring clarifies preserved interhemispheric transfer in humans born without the corpus callosum. Proc Natl Acad Sci USA 2014;111(21): 7843–8.
Parrish ML, Roessmann U, Levinsohn MW. Agenesis of the corpus callosum: a study of the frequency of associated malformations. Ann Neurol 1979;6(4):349–54.
Wahl M, et al. Variability of homotopic and heterotopic callosal connectivity in partial agenesis of the corpus callosum: a 3T diffusion tensor imaging and Q-ball tractography study. Am J Neuroradiol 2009;30:282–289.
Edwards TJ, Sherr EH, Barkovich AJ, Richards LJ. Clinical, genetic and imaging findings identify new causes for corpus callosum development syndromes. Brain. 2014 Jun;137(Pt 6):1579-613.
Plessis AJ, Volpe JJ. Prosencephalic Development. Volpe JJ, Inder TE, Darras BT, Plessis AJ, Neil JJ, Perlman JM, edt. Volpe’s Neurology of the Newborn, 6th edt. Philadelphia: Elsevier; 2018. pp. 34-57.
Cullup T, et al. Recessive mutations in EPG5 cause Vici syndrome, a multisystem disorder with defective autophagy. Nat Genet 2013;45(1):83–7.
Doherty D, et al. GPSM2 mutations cause the brain malformations and hearing loss in Chudley-McCullough syndrome. Am J Hum Genet 2012;90(6):1088–93.
Platzer K, et al. Exome sequencing identifies compound heterozygous mutations in C12orf57 in two siblings with severe intellectual disability, hypoplasia of the corpus callosum, chorioretinal coloboma, and intractable seizures. Am J Med Genet A 2014;164A.
Schaefer GB, et al. The neuroimaging findings in Sotos syndrome. Am J Med Genet 1997;68(4):462–5.
O’Driscoll MC, et al. Identification of genomic loci contributing to agenesis of the corpus callosum. Am J Med Genet A 2010; 152A(9):2145–59.
Guadarrama-Ortiz, P., Choreño-Parra, J. A. & De La Rosa-Arredondo, T. Isolated agenesis of the corpus callosum and normal general intelligence development during postnatal life: A case report and review of the literature. J. Med. Case Rep. 14, 1–7 (2020).
Spadoni AD, et al. Neuroimaging and fetal alcohol spectrum disorders. Neurosci Biobehav Rev 2007;31(2):239–45.
Wainwright P, Gagnon M. Moderate prenatal ethanol exposure interacts with strain in affecting brain development in BALB/c and C57BL/6 mice. Exp Neurol 1985;88(1):84–94.
Jayaram PM, Wake CR. A rare case of absent corpus callosum with severe ventriculomegaly due to congenital herpes simplex infection. J Obstet Gynaecol 2010;30(3):316.
Chiappini E, et al. Congenital cytomegalovirus infection associated with corpus callosum agenesis. Pediatr Neurol 2007; 36(4):277.
Barone S Jr, et al. Gestational exposure to methylmercury alters the developmental pattern of trk-like immunoreactivity in the rat brain and results in cortical dysmorphology. Brain Res Dev Brain Res 1998;109(1):13–31.
Wong, B. K. Y. & Sutton, V. R. Aicardi syndrome, an unsolved mystery: Review of diagnostic features, previous attempts, and future opportunities for genetic examination. Am. J. Med. Genet. Part C Semin. Med. Genet. 178, 423–431 (2018).
Aggarwal D, Majhi D, Padhi TR. Aicardi syndrome in a prematurely born baby with retinopathy of prematurity: eye as a window to a systemic pathology. BMJ Case Rep. 2020 Aug 24;13(8):e235750.
Shevell MI. Clinical and diagnostic profile of agenesis of the corpus callosum. J Child Neurol 2002;17(12):896–900.
Badaruddin DH, et al. Social and behavioral problems of children with agenesis of the corpus callosum. Child Psychiatry Hum Dev 2007;38(4):287–302.
Lau Y, et al. Agenesis of the corpus callosum and the autism spectrum. In: Ninth international meeting for autism research (IMFAR). Philadelphia; 2010 May 20–22.
David AS. Schizophrenia and the corpus callosum: developmental, structural and functional relationships. Behav Brain Res 1994;64(1–2):203–11.
Symington SH, et al. Social cognition in individuals with agenesis of the corpus callosum. Soc Neurosci 2010;5(3): 296–308.
Brown WS, et al. Comprehension of humor in primary agenesis of the corpus callosum. Neuropsychologia 2005;43(6): 906–16.
Preti A, et al. Oxytocin and autism: a systematic review of randomized controlled trials. J Child Adolesc Psychopharmacol 2014;24(2):54–68.
Gutierrez-Castillo, A., Jimenez-Ruiz, A., Chavez-Castillo, M. & Ruiz-Sandoval, J. L. Septo-optic Dysplasia Plus Syndrome. Cureus 10, 1–6 (2018).
Saranac L, Gucev Z. New insights into septo-optic dysplasia. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2014;35(1):123-7.
Ganau, M., Huet, S., Syrmos, N., Meloni, M. & Jayamohan, J. Neuro-ophthalmological manifestations of septo-optic dysplasia: Current perspectives. Eye Brain 11, 37–47 (2019).
Riedl SW, Mullner-Eidenbock A, Prayer D, et al. Auxological, ophthalmological, neurological and MRI findings in 25 Austrian patients with septo-optic dysplasia (SOD). Preliminary data. Horm Res 2002;58(Suppl. 3):16e9.
Tornqvist K, Ericsson A, Kallen B. Optic nerve hypoplasia: risk factors and epidemiology. Acta Ophthalmol Scand 2002;80(3): 300–4.
McNay DE, et al. HESX1 mutations are an uncommon cause of septooptic dysplasia and hypopituitarism. J Clin Endocrinol Metab 2007;92(2):691–7.
Singh V, Boesel CP, Baker P. Septoopticdysplasia and dentatoolivary dysplasia in a case of 18q deletion/3p trisomy. Clin Neuropathol 2004;23(1):28–33.
Riedl S, et al. Refining clinical phenotypes in septoopticdysplasia based on MRI findings. Eur J Pediatr 2008;167(11):1269–76.
Ouvrier R, Billson F. Optic nerve hypoplasia: a review. J Child Neurol. 1986 Jul;1(3):181-8.
Khokhar A, Umpaichitra V, Perez-Colon S. Septo-optic dysplasia among children in Central Brooklyn. Ann Pediatr Child Health 2015.
Ward, D. J., Connolly, D. J. A. & Griffiths, P. D. Review of the MRI brain findings of septo-optic dysplasia. Clin. Radiol. 76, 160.e1-160.e14 (2021).
Webb EA, Dattani MT. Septoopticdysplasia. Eur J Hum Genet 2010;18(4):393–7.
Brodsky MC, et al. Sudden death in septoopticdysplasia. Report of 5 cases. Arch Ophthalmol 1997;115(1):66–70.
Webb EA, Dattani MT. Septo-optic dysplasia. Eur J Hum Genet 2010;18:393e7.
Herrmann, B. W., Hathaway, C. R. & Fadell, M. Hearing Loss in Pediatric Septo-Optic Dysplasia. Ann. Otol. Rhinol. Laryngol. 128, 485–489 (2019).
Sundarakumar DK, Farley SA, Smith CM, Maravilla KR, Dighe MK, Nixon JN. Absent cavum septum pellucidum: a review with emphasis on associated commissural abnormalities. Pediatr Radiol. 2015;45:950-964.
Wang, L. X. et al. The prevalence of cavum septum pellucidum in mental disorders revealed by MRI: A meta-analysis. J. Neuropsychiatry Clin. Neurosci. 32, 175–184 (2020).
Barkovich AJ, Norman D. Absence of the septum pellucidum: a useful sign in the diagnosis of congenital brain malformations. AJR Am J Roentgenol 1989;152(2):353–60.
Lepinard C, et al. Prenatal diagnosis of absence of the septum pellucidum associated with septoopticdysplasia. Ultrasound Obstet Gynecol 2005;25(1):73–5.
Frodl T, et al. Corpus callosum and P300 in schizophrenia. Schizophr Res 2001;49(1–2):107–19.
Bodensteiner JB, Schaefer GB. Wide cavum septum pellucidum: a marker of disturbed brain development. Pediatr Neurol 1990; 6(6):391–4.
